Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.

Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.

Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.